Identification of Isoflavone Derivatives as Effective Anticryptosporidial Agents in Vitro and in Vivo
Andrew V. StachulskiLondon School of Hygiene & Tropical MedicineNeil G. BerryLondon School of Hygiene & Tropical MedicineAudrey LowRomark (United States)Shelley L. MooresRomark Centre for Drug Discovery, Robert Robinson Laboratories, Department of Chemistry, University of Liverpool, Liverpool L69 7ZD, U.K., Romark Research Laboratory, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, U.K., and Romark Institute for Medical Research, 6200 Courtney Campbell Causeway, Suite 200, Tampa, Florida 33607Eleanor C. RowRomark Centre for Drug Discovery, Robert Robinson Laboratories, Department of Chemistry, University of Liverpool, Liverpool L69 7ZD, U.K., Romark Research Laboratory, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, U.K., and Romark Institute for Medical Research, 6200 Courtney Campbell Causeway, Suite 200, Tampa, Florida 33607David C. WarhurstLondon School of Hygiene & Tropical MedicineI. S. AdaguRomark (United States)Jean‐François RossignolRomark (United States)
2006en
ABI
Annotatsiya
We report the preparation and antiparasitic activity in vitro and in vivo of a series of isoflavone derivatives related to genistein. These analogues retain the 5,7-dihydroxyisoflavone core of genistein: direct genistein analogues (2-H isoflavones), 2-carboethoxy isoflavones, and the precursor deoxybenzoins were all evaluated. Excellent in vitro activity against Cryptosporidium parvum was observed for both classes of isoflavones in cell cultures, and the lead compound 19, RM6427, shows high in vivo efficacy against an experimental infection.
Hali tarjima qilinmagan
Identifikatorlar
Iqtiboslar va manbalar
3 ta iqtibos0 ta foydalanilgan manba